Mayo Clinic

Mayo Clinic experts to help guide Delta Air Lines COVID-19 safety measures

Industry leaders in health and travel formalize partnership to transform the future of safe flying
30-Jun-2020 10:05 AM EDT, by Mayo Clinic contact patient services

ROCHESTER, Minn. — Delta Air Lines and Mayo Clinic, a global leader in serious and complex medical care, are deepening their relationship to provide additional safety and COVID-19 infection control measures for customers and employees. The collaboration is another significant step in Delta’s efforts to build upon its foundation of care and cleanliness, known as the Delta CareStandard, to mitigate the risk of transmitting COVID-19 during travel.

"There’s nothing more important than the health and safety of our people and our customers. As we continue adjusting our business to mitigate the risk of COVID-19 transmission, there’s no organization in the world better equipped than the Mayo Clinic to act as Delta’s medical advisor," says Ed Bastian, CEO – Delta Air Lines. "The role Mayo will play in testing our employees and advising on safety practices at airports and work spaces will help deliver the additional layers of protection needed to safeguard our customers and employees."

The Delta CareStandard layers of protection, along with other measures that protect employees, in part contributed to a significant decrease in the number of employees testing positive for COVID-19 between April and May. Since May, the number of employees testing positive is well below the national average. Delta is working closely with expert advisors at Mayo Clinic to review, enhance and continuously improve health and safety protocols.

"The health and safety of employees and customers continues to be our priority during this time of unprecedented uncertainty," says Gianrico Farrugia, M.D., president and chief executive officer, Mayo Clinic. "Mayo Clinic’s expertise in infection prevention and control, as well as our research on COVID-19, provides us with expert insight to support Delta through advisory services, helping to implement best practices to mitigate the spread of COVID-19."

Delta Air Lines will consult with Mayo Clinic on the following:    

  • COVID-19 Testing for Full Delta Workforce – As one of the first Fortune 100 companies to embark on COVID-19 testing for its entire workforce, Delta views testing as a critical step in protecting the health and safety of employees and customers. Mayo Clinic Laboratories has designed Delta’s employee testing program, assisted in administering diagnostic and serology tests, and will analyze the findings to determine broader trends. Based on the findings, Mayo Clinic will provide recommendations to Delta’s existing policies and procedures, perform workforce risk assessments and review re-testing programs for the ongoing safety of Delta people.
  • Establish an Integrated Advisory Council – Comprised of professionals from both organizations, this executive team will meet frequently to review and assess Delta’s health and safety policies and procedures. Mayo Clinic will also provide Delta with ongoing clinical guidance to help mitigate the spread of COVID-19 through enhanced safety measures for employees. This council will be co-led by Rob Kight, senior vice president of Human Relations at Delta, and Henry Ting, M.D., chief value officer at Mayo Clinic, and William Morice II, M.D., Ph.D., president of Mayo Clinic Laboratories.
  • Customer Health Consulting – Working closely with Delta’s Customer Experience team under the guidance of Bill Lentsch, chief customer experience officer, Mayo Clinic will review and provide guidance on current customer-facing protocols and safeguards in place, and provide counsel on how to enhance these measures for optimal results. In addition, Mayo Clinic will advise Delta on best practices for customers regarding COVID-19 prevention, including the use of effective personal protective equipment, and guidance on how Delta can continue to provide a safe and clean travel experience.

"Satisfaction scores among Delta travelers have been at an all-time high during the pandemic, but as more customers return to travel, we understand they’ll need even greater assurances that Delta experiences are safe,” says Lentsch. “This is a journey with no finish line – and we know that more than three quarters of customers, when asked, share that regular employee testing will help boost their confidence in travel. This is the foundation upon which we will innovate and redefine future travel experiences that ensure we are delivering the safe experiences our customers expect and deserve."

"Mayo Clinic has responded to the COVID-19 pandemic by developing innovations in molecular and antibody testing, therapies including convalescent plasma, and protocols and procedures to protect our staff and patients from the spread of infection," says Dr. Ting. "We look forward to collaborating with Delta by using advanced analytics and ongoing testing innovations to help their passengers travel as safely as possible."

Media contact: Ginger Plumbo, Mayo Clinic Public Affairs, newsbureau@mayo.edu

###

About Delta Air Lines
Delta Air Lines (NYSE: DAL) is the U.S. global airline leader in safety, innovation, reliability and customer experience. Powered by our employees around the world, Delta has for a decade led the airline industry in operational excellence while maintaining our reputation for award-winning customer service.

Today, and always, nothing is more important than the health and safety of our customers and employees. Since the onset of the COVID-19 pandemic, Delta has moved quickly to transform the industry standard of clean while offering customers more space across the travel journey. These and numerous other layers of protection ensure a safe and comfortable travel experience for our customers and employees.

With our mission of connecting the people and cultures of the globe, Delta strives to foster understanding across a diverse world and serve as a force for social good. Read more about Delta.

About Mayo Clinic
Mayo Clinic is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the Mayo Clinic News Network for additional Mayo Clinic news and Mayo Clinic Facts for more information about Mayo.




Filters close

Showing results

110 of 2911
Newswise: Obesity a Major Risk for Severe COVID-19 Cases
Released: 13-Aug-2020 4:55 PM EDT
Obesity a Major Risk for Severe COVID-19 Cases
Hackensack Meridian Health

While the U.S. Centers for Disease Control and Prevention (CDC) advises that people of any age can contract COVID-19, obesity has emerged among the major risk factors for severe cases. With more than 40 percent of Americans classified as obese, experts caution that this is a growing concern.

Newswise: Ophthalmologists Anticipate a School Year Marked by Complaints of Eye Strain
Released: 13-Aug-2020 4:10 PM EDT
Ophthalmologists Anticipate a School Year Marked by Complaints of Eye Strain
American Academy of Ophthalmology (AAO)

The American Academy of Ophthalmology shares back-to-online school checklist to protect kids’ eyes from too much screen time.

Newswise: 240042_web.jpg
Released: 13-Aug-2020 3:05 PM EDT
A quick, cost-effective method to track the spread of COVID-19
Hokkaido University

A group of researchers have demonstrated that, from seven methods commonly used to test for viruses in untreated wastewater, an adsorption-extraction technique can most efficiently detect SARS-CoV-2. This gives us another tool to detect the presence and spread of the COVID-19 pandemic.

Released: 13-Aug-2020 2:40 PM EDT
Technion’s Nanofiber PPE Sticker Now In Mass Production
American Technion Society

The COVID-busting ‘Maya’ sticker developed by Technion researchers has gone into mass production. Comprised of a nanofiber sheet, the unique sticker can be easily adhered to a protective mask, significantly improving its effectiveness against the novel coronavirus.

13-Aug-2020 11:00 AM EDT
Massive, rapid vaccine production will require firms to share information
University of Michigan

As the world rushes to identify safe and effective vaccines and therapeutics to counter the COVID-19 epidemic, attention is turning to the next step: manufacturing these products at enormous scale.

Released: 13-Aug-2020 1:05 PM EDT
Additive Manufacturing for COVID-19
Materials Research Society (MRS)

A new Prospective article—Additive Manufacturing for COVID-19: Devices, Materials, Prospects and Challenges—published in MRS Communications, looks at these critical supply issues and provides an overview of 3D printing and how coupling the tools in additive manufacturing (AM) and advanced materials has provided a viable alternative for rapid production and distribution of PPEs and medical devices.

Newswise: Busting Up the Infection Cycle of Hepatitis B
Released: 13-Aug-2020 12:50 PM EDT
Busting Up the Infection Cycle of Hepatitis B
University of Delaware

Researchers at the University of Delaware have gained new understanding of the virus that causes hepatitis B and the “spiky ball” that encloses the virus’s genetic blueprint. They examined how the capsid—a protein shell that protects the blueprint and also drives the delivery of it to infect a host cell—assembles itself. Scientists believe that the capsid is an important target in developing drugs to treat hepatitis B, a life-threatening and incurable infection that afflicts more than 250 million people worldwide.

Newswise: 240097_web.jpg
Released: 13-Aug-2020 12:05 PM EDT
Stay-at-home orders significantly associated with reduced spread of COVID-19, study finds
Brown University

Across the globe, COVID-19 has infected more than 18 million people to date and has killed hundreds of thousands -- and the United States has been hit especially hard.

Released: 13-Aug-2020 11:45 AM EDT
COVID-19 Symptom Tracker Ensures Privacy During Isolation
Georgetown University Medical Center

An online COVID-19 symptom tracking tool developed by researchers at Georgetown University Medical Center ensures a person’s confidentiality while being able to actively monitor their symptoms. The tool is not proprietary and can be used by entities that are not able to develop their own tracking systems.

Newswise: Support for telehealth and mobile health monitoring rises since COVID, study says
Released: 13-Aug-2020 11:25 AM EDT
Support for telehealth and mobile health monitoring rises since COVID, study says
University of Alabama Huntsville

Support for telehealth and mobile health monitoring has risen among healthcare workers and consumers since the rise of the COVID-19 pandemic, according to a new study. Dr. Emil Jovanov, a pioneer in the wearable health monitoring field from The University of Alabama in Huntsville (UAH), participated and was a coauthor.


Showing results

110 of 2911

close
3.01945